Inventor · disambiguated record
Moshe Weitzberg
Also filed as: WEITZBERG MOSHE
10 granted patents·2 pending applications·196 citations·filing 1988–2007
89Inventor score
Top patents by PatentIndex Score
12 records- 0195US4843074A1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary saltsMARION LABORATORIES INC·Filed 1988·Granted Jun 27, 1989·67 cites·7 claims
- 0294US6258822B1Urokinase inhibitorsABBOTT LAB·Filed 1998·Granted Jul 10, 2001·70 cites·5 claims
- 0383US5079260AMethod for treating inflammation and compounds and compositions suitable for use thereinNOVA PHARM CORP·Filed 1990·Granted Jan 7, 1992·23 cites·57 claims
- 0481US7928243B2Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndromeABBOTT LAB·Filed 2007·Granted Apr 19, 2011·4 cites·11 claims
- 0579US8748627B2Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndromeGU YU GUI·Filed 2007·Granted Jun 10, 2014·6 cites·29 claims
- 0676US6284796B1Ukokinase inhibitorsABBOTT LAB·Filed 1999·Granted Sep 4, 2001·20 cites·14 claims
- 0770US6495562B1Naphthamidine urokinase inhibitorsABBOTT LAB·Filed 2001·Granted Dec 17, 2002·5 cites·18 claims
- 0854US8163769B2Antibacterial compoundsANDERSON DAVID·Filed 2003·Granted Apr 24, 2012·1 cites·19 claims
- 0944US8735595B2Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndromeGU YU GUI·Filed 2007·Granted May 27, 2014·0 cites·16 claims
- 1044US2006178400A1Novel acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndromeBEUTEL BRUCE A·Filed 2005·Application pending·0 cites
- 1141US2001049374A1Urokinase inhibitorsFiled 2001·Application pending·0 cites
- 1239US6818654B2Antibacterial compoundsABBOTT LAB·Filed 2003·Granted Nov 16, 2004·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →